Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Asthma

  Free Subscription


Articles published in Respir Med

Retrieve available abstracts of 132 articles:
HTML format
Text format



Single Articles


    June 2019
  1. MANSFIELD L, Bernstein JA
    Tiotropium in asthma: From bench to bedside.
    Respir Med. 2019;154:47-55.
    PubMed     Text format     Abstract available


  2. HUMBERT M, Albers FC, Bratton DJ, Yancey SW, et al
    Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility.
    Respir Med. 2019;154:69-75.
    PubMed     Text format     Abstract available


  3. HONKAMAKI J, Hisinger-Molkanen H, Ilmarinen P, Piirila P, et al
    Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood.
    Respir Med. 2019;154:56-62.
    PubMed     Text format     Abstract available


  4. MULGIRIGAMA A, Barnes N, Fletcher M, Pedersen S, et al
    A review of the burden and management of mild asthma in adults - Implications for clinical practice.
    Respir Med. 2019;152:97-104.
    PubMed     Text format     Abstract available


  5. GRAFF S, Demarche S, Henket M, Paulus V, et al
    Increase in blood eosinophils during follow-up is associated with lung function decline in adult asthma.
    Respir Med. 2019;152:60-66.
    PubMed     Text format     Abstract available


  6. MANISCALCO M, Calabrese C, D'Amato M, Guida P, et al
    Association between exhaled nitric oxide and nasal polyposis in severe asthma.
    Respir Med. 2019;152:20-24.
    PubMed     Text format     Abstract available


  7. MANTYLA J, Mazur W, Torola T, Bergman P, et al
    Asthma as aetiology of bronchiectasis in Finland.
    Respir Med. 2019;152:105-111.
    PubMed     Text format     Abstract available


    May 2019
  8. MATERA MG, Calzetta L, Rogliani P, Cazzola M, et al
    Monoclonal antibodies for severe asthma: Pharmacokinetic profiles.
    Respir Med. 2019;153:3-13.
    PubMed     Text format     Abstract available


  9. KOSKELA HO, Latti AM, Pekkanen J
    Subfreezing air as a cough trigger and multiple triggers are strongly associated with the presence of asthma in chronic cough.
    Respir Med. 2019;153:26-30.
    PubMed     Text format     Abstract available


  10. BAI C, Jiang D, Wang L, Xue F, et al
    A high blood eosinophil count may be a risk factor for incident asthma in population at risk.
    Respir Med. 2019;151:59-65.
    PubMed     Text format     Abstract available


  11. PEREZ DE LLANO L, Martinez-Moragon E, Plaza Moral V, Trisan Alonso A, et al
    Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study.
    Respir Med. 2019;151:49-54.
    PubMed     Text format    


  12. CAZZOLA M, Rogliani P, Calzetta L, Matera MG, et al
    Bronchodilators in subjects with asthma-related comorbidities.
    Respir Med. 2019;151:43-48.
    PubMed     Text format     Abstract available


  13. KERWIN EM, Hickey L, Small CJ
    Relationship between handheld and clinic-based spirometry measurements in asthma patients receiving beclomethasone.
    Respir Med. 2019;151:35-42.
    PubMed     Text format     Abstract available


  14. YANCEY SW, Bradford ES, Keene ON
    Disease burden and efficacy of mepolizumab in patients with severe asthma and blood eosinophil counts of >/=150-300cells/muL.
    Respir Med. 2019;151:139-141.
    PubMed     Text format     Abstract available


  15. LICARI A, Brambilla I, Sacchi L, Marseglia G, et al
    Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children.
    Respir Med. 2019;151:118-120.
    PubMed     Text format     Abstract available


  16. ERIKSSON G, Nolte H, Ljorring C, Riis B, et al
    Comparison of the novel CompEx asthma exacerbation endpoint to the ATS/ERS adapted moderate/severe asthma exacerbation definition used in the MITRA trial.
    Respir Med. 2019;153:1-2.
    PubMed     Text format    


    April 2019
  17. WANG M, Liu M, Wang C, Xiao Y, et al
    Association between vitamin D status and asthma control: A meta-analysis of randomized trials.
    Respir Med. 2019;150:85-94.
    PubMed     Text format     Abstract available


  18. SEGURA-MEDINA P, Vargas MH, Aguilar-Romero JM, Arreola-Ramirez JL, et al
    Mold burden in house dust and its relationship with asthma control.
    Respir Med. 2019;150:74-80.
    PubMed     Text format     Abstract available


  19. TARIQ K, Schofield JPR, Nicholas BL, Burg D, et al
    Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma.
    Respir Med. 2019;150:66-73.
    PubMed     Text format     Abstract available


  20. KATSAOUNOU P, Buhl R, Brusselle G, Pfister P, et al
    Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
    Respir Med. 2019;150:51-62.
    PubMed     Text format     Abstract available


  21. KWON JW, Jung H, Kim SH, Chang YS, et al
    High ACT score is not sufficient to reduce the risk of asthma exacerbations in asthma with low lung function.
    Respir Med. 2019;150:38-44.
    PubMed     Text format     Abstract available


  22. ICHIKAWA T, Panariti A, Audusseau S, Mogas AK, et al
    Effect of bronchial thermoplasty on structural changes and inflammatory mediators in the airways of subjects with severe asthma.
    Respir Med. 2019;150:165-172.
    PubMed     Text format     Abstract available


  23. AARAB R, Vijverberg SJH, Prins M, Snijder MB, et al
    Prevalence of and factors associated with adult-onset asthma in different ethnic groups: The HELIUS study.
    Respir Med. 2019;150:113-119.
    PubMed     Text format     Abstract available


    March 2019
  24. YANG D, Huang T, Liu B, Liu C, et al
    To the editor: Does Continuous Positive Airway Pressure (CPAP) treatment of obstructive sleep apnoea (OSA) improve asthma-related clinical outcomes in patients with co-existing conditions?
    Respir Med. 2019 Mar 16. pii: S0954-6111(19)30079.
    PubMed     Text format    


  25. FARAH CS, Badal T, Reed N, Rogers PG, et al
    Mepolizumab improves small airway function in severe eosinophilic asthma.
    Respir Med. 2019;148:49-53.
    PubMed     Text format     Abstract available


  26. SASSO F, Izard M, Beneteau T, Rakotozandry T, et al
    18-year evolution of asthma and allergic diseases in French urban schoolchildren in relation to indoor air pollutant levels.
    Respir Med. 2019;148:31-36.
    PubMed     Text format     Abstract available


  27. KURUVILLA ME, Vanijcharoenkarn K, Shih JA, Lee FE, et al
    Epidemiology and risk factors for asthma.
    Respir Med. 2019;149:16-22.
    PubMed     Text format    


    February 2019
  28. KOSSE RC, Bouvy ML, de Vries TW, Koster ES, et al
    Effect of a mHealth intervention on adherence in adolescents with asthma: A randomized controlled trial.
    Respir Med. 2019 Feb 16. pii: S0954-6111(19)30045.
    PubMed     Text format     Abstract available


  29. JEMINIWA R, Hohmann L, Qian J, Garza K, et al
    Impact of eHealth on medication adherence among patients with asthma: A systematic review and meta-analysis.
    Respir Med. 2019 Feb 15. pii: S0954-6111(19)30047.
    PubMed     Text format     Abstract available


  30. TAPONEN S, Uitti J, Karvala K, Luukkonen R, et al
    Asthma diagnosed in late adulthood is linked to work disability and poor employment status.
    Respir Med. 2019;147:76-78.
    PubMed     Text format     Abstract available


  31. CIOLKOWSKI J, Emeryk A, Hydzik P, Emeryk-Maksymiuk J, et al
    Eosinophilic airway inflammation is a main feature of unstable asthma in adolescents.
    Respir Med. 2019;147:7-12.
    PubMed     Text format     Abstract available


  32. BJERMER L, Eriksson G, Radner F, Peterson S, et al
    Time to onset of improvements in Quality of Life from Temperature-controlled Laminar Airflow (TLA) in severe allergic asthma.
    Respir Med. 2019;147:19-25.
    PubMed     Text format     Abstract available


    January 2019
  33. KATSOULIS K, Ismailos G, Kipourou M, Kostikas K, et al
    Microbiota and asthma: Clinical implications.
    Respir Med. 2019;146:28-35.
    PubMed     Text format    


  34. BALDACCI S, Simoni M, Maio S, Angino A, et al
    Prescriptive adherence to GINA guidelines and asthma control: An Italian cross sectional study in general practice.
    Respir Med. 2019;146:10-17.
    PubMed     Text format     Abstract available


    December 2018
  35. LIMA-MATOS A, Ponte EV, de Jesus JPV, Almeida PCA, et al
    Eosinophilic asthma, according to a blood eosinophil criterion, is associated with disease severity and lack of control among underprivileged urban Brazilians.
    Respir Med. 2018;145:95-100.
    PubMed     Text format     Abstract available


  36. MATTHES S, Stadler J, Barton J, Leuschner G, et al
    Asthma features in severe COPD: Identifying treatable traits.
    Respir Med. 2018;145:89-94.
    PubMed     Text format     Abstract available


  37. ZENG J, Chen Z, Hu Y, Hu Q, et al
    Asthma control in preschool children with small airway function as measured by IOS and fractional exhaled nitric oxide.
    Respir Med. 2018;145:8-13.
    PubMed     Text format     Abstract available


  38. VON BULOW A, Backer V, Bodtger U, Soes-Petersen NU, et al
    Differentiation of adult severe asthma from difficult-to-treat asthma - Outcomes of a systematic assessment protocol.
    Respir Med. 2018;145:41-47.
    PubMed     Text format     Abstract available


  39. HOSSEINI SA, Zilaee M, Shoushtari MH, Ghasemi Dehcheshmeh M, et al
    An evaluation of the effect of saffron supplementation on the antibody titer to heat-shock protein (HSP) 70, hsCRP and spirometry test in patients with mild and moderate persistent allergic asthma: A triple-blind, randomized placebo-controlled trial.
    Respir Med. 2018;145:28-34.
    PubMed     Text format     Abstract available


  40. PEREIRA AA, Pollard SL, Locke R, Romero K, et al
    Association between exhaled carbon monoxide and asthma outcomes in Peruvian children.
    Respir Med. 2018;145:212-216.
    PubMed     Text format     Abstract available


  41. MAO S, Wu L, Shi W
    Association between trace elements levels and asthma susceptibility.
    Respir Med. 2018;145:110-119.
    PubMed     Text format     Abstract available


    November 2018
  42. NGUYEN TS, Nguyen TLH, Pham TTV, Cao TBT, et al
    Effectiveness of a short training program for community pharmacists to improve knowledge and practice of asthma counselling - A simulated patient study.
    Respir Med. 2018;144:50-60.
    PubMed     Text format     Abstract available


  43. NORDON C, Grimaldi-Bensouda L, Pribil C, Nachbaur G, et al
    Clinical and economic burden of severe asthma: A French cohort study.
    Respir Med. 2018;144:42-49.
    PubMed     Text format     Abstract available


  44. JEPPEGAARD M, Veidal S, Sverrild A, Backer V, et al
    Validation of ATS clinical practice guideline cut-points for FeNO in asthma.
    Respir Med. 2018;144:22-29.
    PubMed     Text format     Abstract available


    October 2018
  45. BUHL R, FitzGerald JM, Busse WW
    Tiotropium add-on to inhaled corticosteroids versus addition of long-acting beta2-agonists for adults with asthma.
    Respir Med. 2018;143:82-90.
    PubMed     Text format     Abstract available


  46. MANSUR AH, Srivastava S, Sahal A
    Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function.
    Respir Med. 2018;143:31-38.
    PubMed     Text format     Abstract available


  47. DAVIES SE, Bishopp A, Wharton S, Turner AM, et al
    Does Continuous Positive Airway Pressure (CPAP) treatment of obstructive sleep apnoea (OSA) improve asthma-related clinical outcomes in patients with co-existing conditions?- A systematic review.
    Respir Med. 2018;143:18-30.
    PubMed     Text format     Abstract available


  48. SCHUERMANS D, Hanon S, Wauters I, Verbanck S, et al
    Impact of a single 10 min education session on asthma control as measured by ACT.
    Respir Med. 2018;143:14-17.
    PubMed     Text format     Abstract available


  49. XIN L, Gao J, Ge X, Tian C, et al
    Increased pro-inflammatory cytokine-secreting regulatory T cells are correlated with the plasticity of T helper cell differentiation and reflect disease status in asthma.
    Respir Med. 2018;143:129-138.
    PubMed     Text format     Abstract available


  50. ALMOMANI BA, Mokhemer E, Al-Sawalha NA, Momany SM, et al
    A novel approach of using educational pharmaceutical pictogram for improving inhaler techniques in patients with asthma.
    Respir Med. 2018;143:103-108.
    PubMed     Text format     Abstract available


    September 2018
  51. MUNESWARAO J, Hassali MA, Verma AK
    Comment on "A novel approach of using educational pharmaceutical pictogram for improving inhaler techniques in patients with asthma".
    Respir Med. 2018 Sep 19. pii: S0954-6111(18)30294.
    PubMed     Text format    


  52. BERTI A, Volcheck GW, Cornec D, Smyth RJ, et al
    Severe/uncontrolled asthma and overall survival in atopic patients with eosinophilic granulomatosis with polyangiitis.
    Respir Med. 2018;142:66-72.
    PubMed     Text format     Abstract available


  53. HEFFLER E, Crimi C, Mancuso S, Campisi R, et al
    Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients.
    Respir Med. 2018;142:48-52.
    PubMed     Text format     Abstract available


  54. CAVALLAZZI R, Jorayeva A, Beatty BL, Antimisiaris D, et al
    Predicting asthma in older adults on the basis of clinical history.
    Respir Med. 2018;142:36-40.
    PubMed     Text format     Abstract available


  55. PELKONEN MK, Notkola IK, Laatikainen TK, Jousilahti P, et al
    30-year trends in asthma and the trends in relation to hospitalization and mortality.
    Respir Med. 2018;142:29-35.
    PubMed     Text format     Abstract available


  56. PAPAIOANNOU AI, Diamant Z, Bakakos P, Loukides S, et al
    Towards precision medicine in severe asthma: Treatment algorithms based on treatable traits.
    Respir Med. 2018;142:15-22.
    PubMed     Text format     Abstract available


    August 2018
  57. PODDIGHE D, Brambilla I, Licari A, Marseglia GL, et al
    Pediatric rhinosinusitis and asthma.
    Respir Med. 2018;141:94-99.
    PubMed     Text format     Abstract available


  58. COUMOU H, Westerhof GA, de Nijs SB, Amelink M, et al
    Diagnosing persistent blood eosinophilia in asthma with single blood eosinophil or exhaled nitric oxide level.
    Respir Med. 2018;141:81-86.
    PubMed     Text format     Abstract available


  59. BAZAN-SOCHA S, Kuczia P, Potaczek DP, Mastalerz L, et al
    Increased blood levels of cellular fibronectin in asthma: Relation to the asthma severity, inflammation, and prothrombotic blood alterations.
    Respir Med. 2018;141:64-71.
    PubMed     Text format     Abstract available


  60. ADACHI M, Kozawa M, Yoshisue H, Lee Milligan K, et al
    Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan.
    Respir Med. 2018;141:56-63.
    PubMed     Text format     Abstract available


  61. SVEDSATER H, Jones R, Bosanquet N, Jacques L, et al
    Patient-reported outcomes with initiation of fluticasone furoate/vilanterol versus continuing usual care in the Asthma Salford Lung Study.
    Respir Med. 2018;141:198-206.
    PubMed     Text format     Abstract available


  62. LYCETT H, Wildman E, Raebel EM, Sherlock JP, et al
    Treatment perceptions in patients with asthma: Synthesis of factors influencing adherence.
    Respir Med. 2018;141:180-189.
    PubMed     Text format     Abstract available


  63. DEVILLIER P, Humbert M, Boye A, Zachgo W, et al
    Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting beta2-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trial.
    Respir Med. 2018;141:111-120.
    PubMed     Text format     Abstract available


  64. GOOD JT JR, Rollins DR, Kolakowski CA, Stevens AD, et al
    New insights in the diagnosis of chronic refractory cough.
    Respir Med. 2018;141:103-110.
    PubMed     Text format     Abstract available


  65. SCHISSLER AJ, Celli BR
    Prevalence of paradoxical bronchoconstriction after inhaled albuterol.
    Respir Med. 2018;141:100-102.
    PubMed     Text format     Abstract available


    July 2018
  66. CHEN A, Nowrouzi-Kia B, Usuba K
    Health-related quality of life in Canadians with asthma: A case-control study using census data.
    Respir Med. 2018;140:82-86.
    PubMed     Text format     Abstract available


  67. POULSEN NN, Bjerregaard A, Khoo SK, Laing IA, et al
    Airway Interleukin-33 and type 2 cytokines in adult patients with acute asthma.
    Respir Med. 2018;140:50-56.
    PubMed     Text format     Abstract available


  68. ZHANG HP, Wang L, Wang Z, Xu XR, et al
    Chinese herbal medicine formula for acute asthma: A multi-center, randomized, double-blind, proof-of-concept trial.
    Respir Med. 2018;140:42-49.
    PubMed     Text format     Abstract available


  69. HENRIKSEN DP, Davidsen JR, Laursen CB
    Nationwide use of theophylline among adults-A 20-year Danish drug utilisation study.
    Respir Med. 2018;140:57-62.
    PubMed     Text format     Abstract available


    June 2018
  70. DE ROOS EW, Lahousse L, Verhamme KMC, Braunstahl GJ, et al
    Asthma and its comorbidities in middle-aged and older adults; the Rotterdam Study.
    Respir Med. 2018;139:6-12.
    PubMed     Text format     Abstract available


  71. MUNGAN D, Aydin O, Mahboub B, Albader M, et al
    Burden of disease associated with asthma among the adult general population of five Middle Eastern countries: Results of the SNAPSHOT program.
    Respir Med. 2018;139:55-64.
    PubMed     Text format     Abstract available


  72. KERWIN E, Wachtel A, Sher L, Nyberg J, et al
    Efficacy, safety, and dose response of glycopyrronium administered by metered dose inhaler using co-suspension delivery technology in subjects with intermittent or mild-to-moderate persistent asthma: A randomized controlled trial.
    Respir Med. 2018;139:39-47.
    PubMed     Text format     Abstract available


  73. KARVALA K, Uitti J, Taponen S, Luukkonen R, et al
    Asthma trigger perceptions are associated with work disability.
    Respir Med. 2018;139:19-26.
    PubMed     Text format     Abstract available


  74. NAKAMOTO K, Saraya T, Ogawa Y, Ishii H, et al
    Comparison of findings on thoracic computed tomography with the severity and duration of bronchial asthma in patients with eosinophilic granulomatosis with polyangiitis.
    Respir Med. 2018;139:101-105.
    PubMed     Text format     Abstract available


    May 2018
  75. ZAFARI Z, Sadatsafavi M, Chen W, FitzGerald JM, et al
    The projected economic and health burden of sub-optimal asthma control in Canada.
    Respir Med. 2018;138:7-12.
    PubMed     Text format     Abstract available


  76. TARRAF H, Al-Jahdali H, Al Qaseer AH, Gjurovic A, et al
    Asthma control in adults in the Middle East and North Africa: Results from the ESMAA study.
    Respir Med. 2018;138:64-73.
    PubMed     Text format     Abstract available


  77. OLUWOLE O, Rennie DC, Senthilselvan A, Dyck R, et al
    The association between endotoxin and beta-(1-->3)-D-glucan in house dust with asthma severity among schoolchildren.
    Respir Med. 2018;138:38-46.
    PubMed     Text format     Abstract available


  78. BACKMAN H, Jansson SA, Stridsman C, Muellerova H, et al
    Chronic airway obstruction in a population-based adult asthma cohort: Prevalence, incidence and prognostic factors.
    Respir Med. 2018;138:115-122.
    PubMed     Text format     Abstract available


  79. KAPPELER D, Sommerer K, Kietzig C, Huber B, et al
    Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler.
    Respir Med. 2018;138:107-114.
    PubMed     Text format     Abstract available


  80. ALBUQUERQUE RODRIGUES FILHO E, Rizzo JA, Goncalves AV, Correia Junior MAV, et al
    Exercise-induced bronchospasm in children and adolescents with allergic rhinitis by treadmill and hyperventilation challenges.
    Respir Med. 2018;138:102-106.
    PubMed     Text format     Abstract available


    April 2018
  81. VAHATALO I, Ilmarinen P, Tuomisto LE, Niemela O, et al
    Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study.
    Respir Med. 2018;137:70-76.
    PubMed     Text format     Abstract available


  82. LIN J, Wang W, Chen P, Zhou X, et al
    Prevalence and risk factors of asthma in mainland China: The CARE study.
    Respir Med. 2018;137:48-54.
    PubMed     Text format     Abstract available


  83. THOMSEN AML, Ehrenstein V, Riis AH, Toft G, et al
    The potential impact of paternal age on risk of asthma in childhood: a study within the Danish National Birth Cohort.
    Respir Med. 2018;137:30-34.
    PubMed     Text format     Abstract available


  84. QU Y, Zhang C, Hu Z, Li S, et al
    The 100 most influential publications in asthma from 1960 to 2017: A bibliometric analysis.
    Respir Med. 2018;137:206-212.
    PubMed     Text format     Abstract available


  85. DY T, Lewis EM, Murugan V, Gehlert S, et al
    Caregiver and pediatric provider perspectives on symptom-based inhaled corticosteroid therapy in asthma.
    Respir Med. 2018;137:201-205.
    PubMed     Text format     Abstract available


  86. KURT OK, Ergun D, Basaran N
    Can the ceramic industry be a new and hazardous sector for work-related asthma?
    Respir Med. 2018;137:176-180.
    PubMed     Text format     Abstract available


  87. WACHTEL H, Nagel M, Engel M, El Azzi G, et al
    In vitro and clinical characterization of the valved holding chamber AeroChamber Plus((R)) Flow-Vu((R)) for administrating tiotropium Respimat((R)) in 1-5-year-old children with persistent asthmatic symptoms.
    Respir Med. 2018;137:181-190.
    PubMed     Text format     Abstract available


  88. LANGTON D, Wang W, Thien F, Plummer V, et al
    The acute effects of bronchial thermoplasty on FEV1.
    Respir Med. 2018;137:147-151.
    PubMed     Text format     Abstract available


  89. CHEROT-KORNOBIS N, Hulo S, Giovannelli J, de Broucker V, et al
    Exhaled breath NOx levels in a middle-aged adults population-based study: reference values and association with the smoking status.
    Respir Med. 2018;137:134-140.
    PubMed     Text format     Abstract available


    March 2018
  90. BRUMPTON BM, Langhammer A, Henriksen AH, Romundstad PR, et al
    Serum 25-hydroxyvitamin D, vitamin D supplement and asthma control: The HUNT study.
    Respir Med. 2018;136:65-70.
    PubMed     Text format     Abstract available


  91. CIPRANDI G, Schiavetti I, Ricciardolo FLM
    The impact of aging on outpatients with asthma in a real-world setting.
    Respir Med. 2018;136:58-64.
    PubMed     Text format     Abstract available


  92. LISSPERS K, Janson C, Larsson K, Johansson G, et al
    Comorbidity, disease burden and mortality across age groups in a Swedish primary care asthma population: An epidemiological register study (PACEHR).
    Respir Med. 2018;136:15-20.
    PubMed     Text format     Abstract available


    February 2018
  93. GOULD CF, Perzanowski MS, Evans D, Bruzzese JM, et al
    Association of exercise-induced wheeze and other asthma symptoms with emergency department visits and hospitalizations in a large cohort of urban adolescents.
    Respir Med. 2018;135:42-50.
    PubMed     Text format     Abstract available


  94. MARTINEZ-RIVERA C, Crespo A, Pinedo-Sierra C, Garcia-Rivero JL, et al
    Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations.
    Respir Med. 2018;135:22-28.
    PubMed     Text format     Abstract available


  95. VARGAS MH, Becerril-Angeles M, Medina-Reyes IS, Rascon-Pacheco RA, et al
    Altitude above 1500m is a major determinant of asthma incidence. An ecological study.
    Respir Med. 2018;135:1-7.
    PubMed     Text format     Abstract available


  96. RODRIGUEZ-JIMENEZ JC, Moreno-Paz FJ, Teran LM, Guani-Guerra E, et al
    Aspirin exacerbated respiratory disease: Current topics and trends.
    Respir Med. 2018;135:62-75.
    PubMed     Text format     Abstract available


  97. KAFAEI SHIRMANESH Y, Jones MD
    Physical ability of people with rheumatoid arthritis and age-sex matched controls to use four commonly prescribed inhaler devices.
    Respir Med. 2018;135:12-14.
    PubMed     Text format     Abstract available


    January 2018
  98. KORENBLAT P, Kerwin E, Leshchenko I, Yen K, et al
    Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids.
    Respir Med. 2018;134:143-149.
    PubMed     Text format     Abstract available


  99. HAUGHNEY J, Morice A, Blyth KG, Lee AJ, et al
    A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels.
    Respir Med. 2018;134:117-123.
    PubMed     Text format     Abstract available


  100. SUZUKAWA M, Matsumoto H, Ohshima N, Tashimo H, et al
    Baseline serum CXCL10 and IL-12 levels may predict severe asthmatics' responsiveness to omalizumab.
    Respir Med. 2018;134:95-102.
    PubMed     Text format     Abstract available


  101. FERGUSON GT, Hickey AJ, Dwivedi S
    Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases.
    Respir Med. 2018;134:16-23.
    PubMed     Text format     Abstract available


    December 2017
  102. NICHOLSON A, Pollard SL, Lima JJ, Romero KM, et al
    Serum folate concentrations, asthma, atopy, and asthma control in Peruvian children.
    Respir Med. 2017;133:29-35.
    PubMed     Text format     Abstract available


  103. LAWSON JA, Brozek G, Shpakou A, Fedortsiv O, et al
    An international comparison of asthma, wheeze, and breathing medication use among children.
    Respir Med. 2017;133:22-28.
    PubMed     Text format     Abstract available


  104. SZENTPETERY SS, Gruzieva O, Forno E, Han YY, et al
    Combined effects of multiple risk factors on asthma in school-aged children.
    Respir Med. 2017;133:16-21.
    PubMed     Text format     Abstract available


  105. VILMANN L, Buchvald F, Green K, Nielsen KG, et al
    Fractional exhaled nitric oxide and multiple breath nitrogen washout in preschool healthy and asthmatic children.
    Respir Med. 2017;133:42-47.
    PubMed     Text format     Abstract available


    November 2017
  106. JUDSON MA
    Endpoints in sarcoidosis: More like IPF or asthma?
    Respir Med. 2017 Nov 20. pii: S0954-6111(17)30384.
    PubMed     Text format    


  107. SVEDSATER H, Leather D, Robinson T, Doll H, et al
    Evaluation and quantification of treatment preferences for patients with asthma or COPD using discrete choice experiment surveys.
    Respir Med. 2017;132:76-83.
    PubMed     Text format     Abstract available


  108. CONDREAY L, Chiano M, Ortega H, Buchan N, et al
    No genetic association detected with mepolizumab efficacy in severe asthma.
    Respir Med. 2017;132:178-180.
    PubMed     Text format     Abstract available


  109. SUNDH J, Wireklint P, Hasselgren M, Montgomery S, et al
    Health-related quality of life in asthma patients - A comparison of two cohorts from 2005 and 2015.
    Respir Med. 2017;132:154-160.
    PubMed     Text format     Abstract available


  110. LEE J, Kronborg C, O'Hehir RE, Hew M, et al
    Who's at risk of thunderstorm asthma? The ryegrass pollen trifecta and lessons learnt from the Melbourne thunderstorm epidemic.
    Respir Med. 2017;132:146-148.
    PubMed     Text format     Abstract available


  111. PENG YH, Su SY, Liao WC, Huang CW, et al
    Asthma is associated with endometriosis: A retrospective population-based cohort study.
    Respir Med. 2017;132:112-116.
    PubMed     Text format     Abstract available


  112. MAZENQ J, Dubus JC, Gaudart J, Charpin D, et al
    City housing atmospheric pollutant impact on emergency visit for asthma: A classification and regression tree approach.
    Respir Med. 2017;132:1-8.
    PubMed     Text format     Abstract available


  113. BLAIS CM, Davis BE, Cockcroft DW
    Diversity of methacholine dose-response curves among asymptomatic non-asthmatics.
    Respir Med. 2017;132:109-111.
    PubMed     Text format    


    October 2017
  114. BAKIRTAS A, Kutlu A, Baccioglu A, Erkekol FO, et al
    Physicians' preference for controller medication in mild persistent asthma.
    Respir Med. 2017;131:236-240.
    PubMed     Text format     Abstract available


  115. LI N, Qiu R, Yang Z, Li J, et al
    Sputum microbiota in severe asthma patients: Relationship to eosinophilic inflammation.
    Respir Med. 2017;131:192-198.
    PubMed     Text format     Abstract available


  116. SCHMIDT O, Petro W, Hoheisel G, Kanniess F, et al
    Real-life effectiveness of asthma treatment with a fixed-dose fluticasone/formoterol pressurised metered-dose inhaler - Results from a non-interventional study.
    Respir Med. 2017;131:166-174.
    PubMed     Text format     Abstract available


  117. FITZGERALD JM, Tavakoli H, Lynd LD, Al Efraij K, et al
    The impact of inappropriate use of short acting beta agonists in asthma.
    Respir Med. 2017;131:135-140.
    PubMed     Text format     Abstract available


  118. ZIERAU L, Walsted ES, Thomsen SF, Backer V, et al
    Response to omalizumab in patients with severe allergic asthma: A real-life study.
    Respir Med. 2017;131:109-113.
    PubMed     Text format     Abstract available


    September 2017
  119. TALINI D, Ciberti A, Bartoli D, Del Guerra P, et al
    Work-related asthma in a sample of subjects with established asthma.
    Respir Med. 2017;130:85-91.
    PubMed     Text format     Abstract available


  120. MANISCALCO M, Zamparelli AS, Vitale DF, Faraone S, et al
    Long-term effect of weight loss induced by bariatric surgery on asthma control and health related quality of life in asthmatic patients with severe obesity: A pilot study.
    Respir Med. 2017;130:69-74.
    PubMed     Text format     Abstract available


  121. DI BONA D, Fiorino I, Taurino M, Frisenda F, et al
    Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study.
    Respir Med. 2017;130:55-60.
    PubMed     Text format     Abstract available


  122. COX CA, Boudewijn IM, Vroegop SJ, Schokker S, et al
    Extrafine compared to non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.
    Respir Med. 2017;130:35-42.
    PubMed     Text format     Abstract available


  123. TANNO LK, Haahtela T, Calderon MA, Cruz A, et al
    Implementation gaps for asthma prevention and control.
    Respir Med. 2017;130:13-19.
    PubMed     Text format     Abstract available


    August 2017
  124. KWON JW, Chang HS, Heo JS, Bae DJ, et al
    Characteristics of asthmatics with detectable IL-32gamma in induced sputum.
    Respir Med. 2017;129:85-90.
    PubMed     Text format     Abstract available


    June 2017
  125. LIN J, Li J, Yu W, Liu Y, et al
    A multicenter, cross-sectional, observational study of budesonide/formoterol maintenance and reliever therapy in real-world settings.
    Respir Med. 2017;127:45-50.
    PubMed     Text format     Abstract available


  126. MACEDO P, Zhang Q, Saito J, Liang Z, et al
    Analysis of bronchial biopsies in chronic cough.
    Respir Med. 2017;127:40-44.
    PubMed     Text format     Abstract available


    March 2017
  127. ROGLIANI P, Calzetta L, Coppola A, Cavalli F, et al
    Optimizing drug delivery in COPD: The role of inhaler devices.
    Respir Med. 2017;124:6-14.
    PubMed     Text format     Abstract available


    February 2017
  128. LEE JU, Chang HS, Lee HJ, Bae DJ, et al
    Association of interleukin-25 levels with development of aspirin induced respiratory diseases.
    Respir Med. 2017;123:71-78.
    PubMed     Text format     Abstract available


    January 2017
  129. LI JX, Fan LC, Li MH, Cao WJ, et al
    Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature.
    Respir Med. 2017;122:33-42.
    PubMed     Text format     Abstract available


    October 2016
  130. SPOSATO B, Scalese M, Latorre M, Scichilone N, et al
    Effects of omalizumab in severe asthmatics across ages: A real life Italian experience.
    Respir Med. 2016;119:141-149.
    PubMed     Text format     Abstract available


    September 2016
  131. BLAIS CM, Davis BE, Cockcroft DW
    Duration of bronchoprotection of the long-acting muscarinic antagonists tiotropium & glycopyrronium against methacholine-induced bronchoconstriction in mild asthmatics.
    Respir Med. 2016;118:96-101.
    PubMed     Text format     Abstract available


    August 2016
  132. VERMEULEN F, Garcia G, Ninane V, Laveneziana P, et al
    Activity limitation and exertional dyspnea in adult asthmatic patients: What do we know?
    Respir Med. 2016;117:122-30.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: